Kick off 2026 with a competitive edge at PACK EXPO East. Register now!
Get a jump on your 2026 goals at PACK EXPO East. Put projects in motion, accelerate timelines and solve challenges—all in one trip to Philadelphia.

FDA promotes safe use of pain products

The Food and Drug Administration launched a national education campaign to promote safer use of over-the-counter pain relief products, particularly those containing acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs), such as aspirin, ibuprofen, naproxen sodium, and ketoprofen.

Pw 13433 Rules Regs1

Although widely used, misuse can be harmful. FDA estimates that 56ꯠ emergency room visits and 100 deaths a year are due to acetaminophen overdose. FDA is urging consumers to read labels carefully and follow the directions.

FDA noted that in September 2002 its Non-Prescription Drugs Advisory Committee recommended labeling changes for certain OTC drugs, including acetaminophen and NSAIDs, to better inform consumers about the ingredients in the products and possible side effects from improper use. FDA said it will consider labeling changes and is reviewing changes that better reflect the latest scientific thinking.

List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO
Get a jump on your 2026 packaging & processing goals at PACK EXPO East.
Be the first to find what’s next in packaging & processing at PACK EXPO East. See new solutions from 500 exhibitors, uncover creative ideas for 40+ verticals and gain inspiration from free sessions on industry trends—all in one trip to Philadelphia.
REGISTER NOW & SAVE
Get a jump on your 2026 packaging & processing goals at PACK EXPO East.